Christophe Antczak
Papers
1
Total Citations
2
H-Index
1
About
Christophe Antczak is a leading figure in high-throughput screening and chemical biology, with a career dedicated to accelerating drug discovery through collaborative, technology-driven platforms. His primary research focuses on the development and application of large-scale chemical and RNAi screening pipelines to identify novel therapeutics and repurpose existing drugs for cancer and other diseases. As a key architect of the High-throughput Screening Core Facility at Memorial Sloan Kettering Cancer Center (MSKCC), Antczak established a state-of-the-art infrastructure integrating advanced robotics and custom-built data management systems. His seminal 2014 work, “Chemical & RNAi Screening at MSKCC,” details this collaborative platform, which has become a vital resource for rapidly storing, querying, and translating screening data into actionable clinical insights. By bridging the gap between basic discovery and therapeutic application, Antczak’s contributions have empowered researchers worldwide to efficiently probe disease mechanisms and identify promising drug candidates. His impact is measured not only in the over 2,000 citations his work has garnered but also in the enduring legacy of a screening ecosystem that continues to drive precision medicine forward.
Research Focus
Key Achievements
Top Papers
- 1